HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giulia Piaggio Selected Research

TA protocol

1/2022Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giulia Piaggio Research Topics

Disease

29Neoplasms (Cancer)
04/2022 - 07/2003
7Endometrial Neoplasms (Endometrial Cancer)
04/2022 - 01/2017
5Inflammation (Inflammations)
04/2022 - 07/2009
5COVID-19
01/2022 - 01/2021
4Adenocarcinoma
01/2021 - 09/2016
4Breast Neoplasms (Breast Cancer)
01/2020 - 07/2014
3Non-Muscle Invasive Bladder Neoplasms
10/2021 - 10/2019
3Carcinogenesis
10/2021 - 03/2016
3Urinary Bladder Neoplasms (Bladder Cancer)
11/2020 - 10/2019
2Hypertension (High Blood Pressure)
06/2021 - 12/2017
2Thyroid Neoplasms (Thyroid Cancer)
04/2021 - 08/2014
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
07/2009 - 12/2008
1Frailty
01/2022
1Infections
10/2021
1Alcoholism (Alcohol Abuse)
10/2021
1Euthyroid Sick Syndromes (Euthyroid Sick Syndrome)
01/2021
1Medulloblastoma
01/2021
1Multiple Myeloma
01/2021
1Polycythemia Vera
01/2021
1Essential Thrombocythemia
01/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Primary Myelofibrosis (Myelosclerosis)
01/2021
1Uterine Diseases (Endometrial Disease)
03/2019
1Progeria (Hutchinson Gilford Syndrome)
10/2018
1Carcinoma (Carcinomatosis)
07/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2018
1Cardiotoxicity
01/2017
1Neurologic Manifestations (Neurological Manifestations)
12/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2016
1Hyperbilirubinemia
01/2016
1Brain Neoplasms (Brain Tumor)
01/2016
1Colonic Neoplasms (Colon Cancer)
01/2016
1Glioma (Gliomas)
01/2016
1Genomic Instability
04/2015

Drug/Important Bio-Agent (IBA)

15Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2016
7MicroRNAs (MicroRNA)IBA
11/2020 - 06/2014
5Proteins (Proteins, Gene)FDA Link
10/2021 - 07/2003
4BNT162 VaccineIBA
10/2021 - 01/2021
4VaccinesIBA
10/2021 - 01/2021
3Cell-Free Nucleic AcidsIBA
04/2022 - 12/2017
3Biological ProductsIBA
01/2022 - 01/2016
3Lamin Type A (Lamin A)IBA
10/2021 - 01/2017
2Histones (Histone)IBA
04/2022 - 07/2009
2CytokinesIBA
10/2021 - 01/2021
2IodineIBA
04/2021 - 08/2014
2Thyrotropin Receptors (Thyrotropin Receptor)IBA
04/2021 - 08/2014
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
03/2019 - 07/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2018
2Estrogen ReceptorsIBA
01/2017 - 01/2016
2ChromatinIBA
01/2016 - 07/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2009 - 12/2008
1InterferonsIBA
10/2021
1Ethanol (Ethyl Alcohol)IBA
10/2021
1LaminsIBA
10/2021
1Messenger RNA (mRNA)IBA
10/2021
1glabrescione BIBA
01/2021
1ruxolitinibIBA
01/2021
1mRNA VaccinesIBA
01/2021
1GemcitabineFDA Link
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1MicellesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021
1Neutralizing AntibodiesIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
08/2020
1human MIRN143 microRNAIBA
02/2020
1artenimol (dihydroartemisinin)IBA
01/2020
1PoisonsIBA
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1LuciferasesIBA
01/2019
1Complementary DNA (cDNA)IBA
01/2019
1Cell Adhesion MoleculesIBA
07/2018
1N(6)-carboxymethyllysine (carboxymethyllysine)IBA
01/2018
1Advanced Glycation End ProductsIBA
01/2018
1GoldIBA
12/2017
1Angiogenesis InhibitorsIBA
06/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1CXC ChemokinesIBA
01/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017
1Chemokine CXCL12IBA
01/2017
1BilirubinIBA
12/2016
1AlbuminsIBA
12/2016
1Cre recombinaseIBA
09/2016
1Transcription Factors (Transcription Factor)IBA
01/2016
1Carbon Nanotubes (Carbon Nanotube)IBA
01/2016
1Alanine Transaminase (SGPT)IBA
01/2016
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2016
1Peptides (Polypeptides)IBA
11/2015
1Phosphotransferases (Kinase)IBA
04/2015

Therapy/Procedure

7Therapeutics
01/2022 - 07/2014
2Immunotherapy
07/2021 - 01/2020
1TA protocol
01/2022
1Drug Therapy (Chemotherapy)
01/2020
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018
1Intravenous Administration
10/2015